AGBL2 and inflammatory bowel disease: In another study, serum antibodies against anti-mutated citrullinated vimentin (anti-MCV) and second-generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies were measured in 125 IBD patients, 35% of which had SpA/IBD [81].